Search Within

Marissa Mattar

Refine Results
Formats
  1. Journal Article (4)
  2. Book Section (3)
  3. Meeting Abstract (1)
Groups
  1. Human Oncology and Pathogenesis Program (5)
  2. Solid Tumor Oncology Division (4)
  3. Center for Hematologic Malignancies (3)
  4. Hematologic Oncology, Division of (3)
  5. Thoracic Malignancies Disease Management Team (3)
  6. Executive Committee, Center for Hematologic Malignancies (2)

More Groups

People
  1. Elisa De Stanchina (7)
  2. Besnik Qeriqi (2)
  3. Inna Khodos (2)
  4. Maurizio Scaltriti (2)
  5. Omar Abdel-Wahab (2)
  6. Ahmet Dogan (1)

More People

Years
  1. 2019 (2)
  2. 2018 (1)
  3. 2017 (4)
  4. 2016 (1)
Publications
  1. Patient Derived Tumor Xenograft Models: Promise, Potential and Practice (3)
  2. Blood (1)
  3. Cancer Discovery (1)
  4. Clinical Cancer Research (1)
  5. Frontiers in Oncology (1)
  6. OncoImmunology (1)
Publishers
  1. Academic Press, Elsevier Inc (3)
  2. American Association for Cancer Research (2)
  3. American Society of Hematology (1)
  4. Frontiers Media S.A. (1)
  5. Landes Bioscience (1)

Results (8)

Export to EndNote | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • EGFR and MET amplifications determine response to HER2 inhibition in ERBB2-amplified esophagogastric cancer
    Journal Article

    Sanchez-Vega, F.; Hechtman, J. F.; Castel, P.; Ku, G. Y.; Tuvy, Y.; Won, H.; Fong, C. J.; Bouvier, N.; Nanjangud, G. J.; Soong, J.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Activation of KRAS mediates resistance to targeted therapy in MET exon 14–mutant non–small cell lung cancer
    Journal Article

    Suzawa, K.; Offin, M.; Lu, D.; Kurzatkowski, C.; Vojnic, M.; Smith, R. S.; Sabari, J. K.; Tai, H.; Mattar, M.; Khodos, I.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Establishing and maintaining an extensive library of patient-derived xenograft models
    Journal Article

    Mattar, M.; McCarthy, C. R.; Kulick, A. R.; Qeriqi, B.; Guzman, S.; de Stanchina, E.
    Frontiers in Oncology (2018)

    Fulltext@MSK | Save
  • Generation and application of T-cell lymphoma patient derived tumor xenograft models
    Meeting Abstract

    Fiore, D.; Wang, X.; Khodos, I.; Di Giacomo, F.; Gaudiano, M.; Phillip, J. M.; Wang, R.; Yang, Z.; Ginsberg, M.; Intlekofer, A. M.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Running a PDX core laboratory or a PDX support program
    Book Section

    Krivtsov, A.; Mattar, M.; Uthamanthil, R. K.; de Stanchina, E.
    In Uthamanthil, R.; Tinkey, P; de Stanchina, E. (Eds.) Patient Derived Tumor Xenograft Models: Promise, Potential and Practice (2017)

    Fulltext@MSK | Save
  • Acquisition and storage of clinical samples to establish PDX models
    Book Section

    Mattar, M.; Abdel-Wahab, O.; de Stanchina, E.
    In Uthamanthil, R.; Tinkey, P.; de Stanchina, E. (Eds.) Patient Derived Tumor Xenograft Models: Promise, Potential and Practice (2017)

    Fulltext@MSK | Save
  • Methodologies for developing and maintaining patient-derived xenograft mouse models
    Book Section

    Mattar, M.; Abdel-Wahab, O.; Poirier, J. T.; Scaltriti, M.; de Stanchina, E.
    In Uthamanthil, R.; Tinkey, P.; de Stanchina, E. (Eds.) Patient Derived Tumor Xenograft Models: Promise, Potential and Practice (2017)

    Fulltext@MSK | Save
  • Timing of CSF-1/CSF-1R signaling blockade is critical to improving responses to CTLA-4 based immunotherapy
    Journal Article

    Holmgaard, R. B.; Brachfeld, A.; Gasmi, B.; Jones, D. R.; Mattar, M.; Doman, T.; Murphy, M.; Schaer, D.; Wolchok, J. D.; Merghoub, T.
    OncoImmunology (2016)

    Fulltext@MSK | Save